Marizyme, Inc.
MRZM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,590 | $5,997 | $12,520 | $4,547 |
| - Cash | $64 | $5 | $6 | $148 |
| + Debt | $26,658 | $20,454 | $23,557 | $18,717 |
| Enterprise Value | $33,184 | $26,446 | $36,071 | $23,116 |
| Revenue | $0 | $0 | $33 | $151 |
| % Growth | – | -100% | -78.2% | – |
| Gross Profit | -$211 | -$223 | -$186 | -$116 |
| % Margin | – | – | -566.4% | -77.4% |
| EBITDA | -$644 | -$912 | -$1,855 | -$7,838 |
| % Margin | – | – | -5,646% | -5,205.7% |
| Net Income | -$1,960 | -$4,073 | -$6,226 | -$9,766 |
| % Margin | – | – | -18,949.9% | -6,486.4% |
| EPS Diluted | -0.015 | -0.031 | -0.047 | -0.19 |
| % Growth | 51.8% | 34.5% | 75.2% | – |
| Operating Cash Flow | -$983 | -$750 | -$850 | -$1,257 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$983 | -$750 | -$850 | -$1,257 |